Solynta and Incotec Announce Partnership to Optimize Performance of Hybrid True Potato Seeds
16.5.2022 13:00:00 EEST | Business Wire | Press release
Hybrid potato innovator Solynta and seed enhancement company Incotec have entered in a collaboration agreement. By combining forces, the group will bring world-class seed technology and elite genetics to potato farmers worldwide.
Solynta is a Netherlands-based company using hybrid potato breeding to grow a more sustainable future. Solynta has developed a unique portfolio of hybrid potato varieties for farmers that are dependable, productive and resilient to climate change. Incotec, a global seed enhancement company, has developed technologies including a new pelletization method and seed priming formula specifically tailored for true potato seeds. This seed technology will allow Solynta’s true potato seeds to succeed in diverse growing environments.
Johan Trouw, Solynta Supply Chain Director and co-founder, noted, “At Solynta, we believe that partnering with industry leaders like Incotec supports our mission of creating solutions for food and nutritional insecurity. Their expertise in seed enhancement combined with our hybrid breeding technology will have a major impact on the future of global potato crops.”
Erik Jan Bartels, Incotec Managing Director, added, “Incotec is continuously innovating and improving its product portfolio. Extending our seed enhancement technologies to true potato seeds is a significant step forward toward creating a more sustainable food-secure future. We value the cooperation with Solynta and are thrilled to be a partner in their revolutionary work.”
About Solynta
Solynta is a Dutch agriculture innovator using hybrid potato breeding to grow a more sustainable future. Solynta’s mission is to help create global solutions for food and nutritional insecurity by giving farmers better, stronger and more cost-efficient ways to grow crops. Solynta’s true potato seeds combine years of agricultural experience with the newest hybrid breeding technologies. To learn more about their mission to unlock the true potential of potatoes, visit www.solynta.com.
About Incotec
Incotec is a leading international seed enhancement company founded in 1968 and part of the Croda Group. Croda summarises its purpose as ‘Smart Science to Improve Lives’. Incotec aims to contribute to feeding the world by providing key solutions for sustainable agriculture. Incotec provides seed enhancing products and services like seed coating, pelleting, seed enhancement and analytical services. Incotec is headquartered in the Netherlands and has production facilities around the world. For more information go to www.incotec.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220512005887/en/
Contact information
Press contact:
- Rachel Pipan, press@solynta.com
- Marion Smorenburg, marion.smorenburg@incotec.com, +31 (0)6 50874446
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Inc. to Host Third Quarter 2026 Financial Results Conference Call on November 5, 202613.10.2026 15:30:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced that it has scheduled a conference call to discuss its financial results for the third quarter ended September 30, 2026. The call will be hosted on Thursday, November 5, 2026, at 8:30 a.m. Eastern Time by Razat Gaurav, Chief Executive Officer, and Herb Yeh, Chief Financial Officer and Chief Strategy Officer, followed by a question and answer period. The Company will report its financial results for the third quarter after the close of markets on Wednesday, November 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, November 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/703967106 About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniqu
Seequent Launches AI-Powered Imago Image Analysis to Accelerate Geological Core Logging13.10.2026 15:00:00 EEST | Press release
Seequent, The Bentley Subsurface Company, has launched Imago image analysis, a new AI-powered capability built directly into its cloud-based solution Imago for extracting knowledge from geoscientific imagery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261013282684/en/ Imago image analysis results showing core condition, fracture polylines, and AutoCrop boundaries on diamond-drilled core. Core condition delineates solid (blue), broken (orange), depth blocks (green), and gaps in recovered core. With the new Imago image analysis add-on, geologists can analyse drill core imagery in minutes, dramatically accelerating analysis that has traditionally taken days or weeks. It generates consistent, high-confidence quantitative geological data to support modelling and exploration decisions, helping teams from junior explorers to mining majors derive greater value from drilling programmes. Purpose-built machine-learning models autom
ExaGrid Announces Record 3 rd Quarter Bookings and Revenue13.10.2026 15:00:00 EEST | Press release
ExaGrid®, the world’s largest independent backup storage vendor providing Tiered Backup Storage with the fastest backups, fastest restores, largest backup storage scale-out system with deduplication, and the most comprehensive security and AI-Powered Retention Time-Lock for Ransomware Recovery, today announced that it had its best ever third quarter for bookings and revenue in the quarter ending September 30, 2026, with double-digit revenue growth over Q3 of 2025 and double-digit revenue growth for the first nine months of 2026 over 2025. ExaGrid has exceeded its plan in all three quarters of 2026 and is ahead of plan on its way to a record bookings and revenue year. ExaGrid’s growth rate is accelerating. In addition, ExaGrid remained P&L, EBITDA, and free cash flow positive for the 23rd consecutive quarter. The company is 100% debt-free, demonstrating strong financial health as a company. ExaGrid had its highest percentage of bookings coming from deals over $1M. Highlights of Q3 2026:
What Europeans Really Want From Their Next Smartphone13.10.2026 14:01:00 EEST | Press release
If you’ve ever bought running shoes for the runner you hoped to become or luggage for a yet to be planned trip, you’re not alone. New research from Samsung reveals that Europeans1 take a similar aspirational approach when choosing a smartphone. More than two thirds (66%2) of Europeans surveyed1 chose their current smartphone with at least one interest they wanted to pursue in mind, with interests ranging from entertainment and side hustles to gaming, travel and content creation. In fact, almost half (46%3) consider their ambitions when making technology choices, including 24% who say their choices are primarily shaped by the life they aspire to lead. Additionally, almost a third (28%) reported that they chose their current smartphone to better reflect their personal style. Having a variety of options to choose from is important when considering the wide range of aspirations and focuses of European consumers. Big ambitions, everyday needs Europeans1 may be choosing smartphones with futu
Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61-Targeting Small Molecules13.10.2026 14:00:00 EEST | Press release
Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, today announced it has entered into a research collaboration and license agreement with Pfizer Inc. to discover and develop Sec61 inhibitors. The collaboration aims to accelerate the discovery and advancement of novel small-molecule therapeutics leveraging Enodia’s proprietary platform. Enodia’s proprietary platform enables selective Sec61 Translocon modulation, a novel approach to inhibit disease-driving proteins at the point of synthesis before pathological effects occur, while preserving essential physiological functions. Enodia has built a broad and well-characterized chemical space spanning multiple Sec61 inhibitor families, supported by extensive biological datasets, including proteomics, cryo-EM and tailored cell-line libraries that enable rational small-molecule design powered by machine learning. “Enodia has built a broad platform t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom